Project Grant R01AI187204
Award Date
8/1/25
Completion Date
7/31/30
Dollars Obligated
$577K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Texas, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $626,423 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Texas Medical Branch at Galveston (UTMB). The funding will support research to explore the dependence of arenaviruses on the metabolism of the monosaccharides D-glucose and D-mannose, with the goal of developing carbohydrate antimetabolite compounds as potential pan-arenavirus therapeutics. Specifically,...
This Project Grant award of $536,871 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to identify pan-arenavirus sites of vulnerability through machine learning and artificial neural network molecular screening of small molecules against arenavirus glycoprotein complexes (GPC) and RNA polymerases (RNAP). The proposed research seeks to define molecular specificities and commonalities across...
This Project Grant award, valued at $681,755.00 and issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research into the intracellular assembly, maturation, and trafficking of glycoprotein complexes from four rodent-infecting hantaviruses. The research aims to delineate the virus-host interactions required for the proper localization and function of these glycoprotein complexes, which...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $192,889 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Texas at Austin. The grant, awarded on November 12, 2024, aims to optimize the expression of short hairpin RNA (shRNA) in polyomavirus (PYV) genomes and conduct a proof-of-principle screen to assess how shRNA-armed PYVs can help unravel the mechanisms of PYV persistence and reactivation. This research is...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $242,185 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Texas A&M Agrilife Research. The grant supports research to investigate the role of RNA structure in regulating developmental RNA editing in pathogenic trypanosomes, such as Trypanosoma brucei. The key objectives are to: 1) Develop a new technique to assess RNA structure under native cellular conditions versus in vitro,...
This federal Project Grant award of $440,000 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research at the University of Texas Medical Branch at Galveston (UTMB) to characterize the role of TRIM proteins in the host innate antiviral immunity against vector-borne bunyavirus infections. The project aims to (1) identify TRIM proteins that regulate bunyavirus infection and (2) define...
This federal Project Grant award of $798,400 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to investigate the use of circular RNA vaccines to improve the durability of the immune response, compared to linear mRNA vaccines. The research project, conducted by the University of Texas Medical Branch at Galveston, will pursue three specific aims: 1) Investigate the innate immune responses induced by...
This Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $128,052 to Virginia Polytechnic Institute & State University (Virginia Tech) to investigate the role of the Rift Valley Fever Virus (RVFV) non-structural small (NSS) protein in modulating the host autophagy pathway. The project aims to define the molecular mechanism of the NSS-LC3 interaction and assess its impact...
This Project Grant award of $440,000 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), supports research conducted by the University of Texas Medical Branch at Galveston (UTMB). The project aims to investigate the role of Rickettsia parkeri's cold shock protein A (CspA) as an exosome-specific RNA-binding protein that selectively enriches detrimental microRNAs (miR23a/27a/24/30b) in...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $143,450 to support research on developing therapies for treating viral-induced acute lung injury. The primary focus is on evaluating the therapeutic efficacy of combinations of PPARG agonist and RXR ligand compounds in cotton rat models of influenza and respiratory syncytial virus (RSV) infection. The research...